BCRX - Company ID 0000882796
BIOCRYST PHARMACEUTICALS INC (BCRX) reported revenue of $874.84M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $874.84M | +94.1% |
| FY 2024 | $450.71M | +36.0% |
| FY 2023 | $331.41M | +22.4% |
| FY 2022 | $270.83M | +72.3% |
| FY 2021 | $157.17M | +782.4% |
| FY 2020 | $17.81M | -63.5% |
| FY 2019 | $48.84M | +136.5% |
| FY 2018 | $20.65M | -18.0% |
| FY 2017 |
BIOCRYST PHARMACEUTICALS INC (BCRX) reported revenue of $874.84M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, BIOCRYST PHARMACEUTICALS INC's revenue grew from $19.64M to $874.84M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $25.19M |
| -4.4% |
| FY 2016 | $26.35M | -45.4% |
| FY 2015 | $48.26M | +254.6% |
| FY 2014 | $13.61M | -21.5% |
| FY 2013 | $17.33M | -34.1% |
| FY 2012 | $26.29M | +33.9% |
| FY 2011 | $19.64M | - |